CAMPIA, IVANA
CAMPIA, IVANA
A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells
2011-01-01 Kopecka J; Campia I; Olivero P; Pescarmona GP; Ghigo D; Bosia A; Riganti C
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells
2015-01-01 Campia, Ivana; Buondonno, Ilaria; Castella, Barbara; Rolando, Barbara; Kopecka, Joanna; Gazzano, Elena; Ghigo, Dario; Riganti, Chiara
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells
2015-01-01 J. Kopecka; I. Campia; A. Jacobs; AP. Frei; D. Ghigo; B. Wollscheid; C. Riganti
Cardiac glycosides as new modulators of cholesterol metabolism
2012-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation
2013-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1
2012-01-01 I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti
Classical inhibitors of NOX NAD(P)H oxidases are not specific
2008-01-01 Aldieri E; Riganti C; Polimeni M; Gazzano E; Lussiana C; Campia I; Ghigo D
Digoxin and ouabain increase the synthesis of cholesterol in human liver cells
2009-01-01 Campia I; Gazzano E; Pescarmona G; Ghigo D; Bosia A; Riganti C
Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1alpha in human colon cancer cells
2009-01-01 Riganti C; Campia I; Polimeni M; Pescarmona G; Ghigo D; Bosia A
Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes.
2012-01-01 Campia I; Sala V; Kopecka J; Leo C; Mitro N; Costamagna C; Caruso D; Pescarmona G; Crepaldi T; Ghigo D; Bosia A; Riganti C.
Digoxin and oubain increase the synthesis of cholesterol in human liver cells
2011-01-01 Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti
Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis
2009-01-01 Campia I; Lussiana C; Pescarmona GP; Ghigo D; Bosia A; Riganti C
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS
2011-01-01 Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition.
2014-01-01 J. Kopecka; G. Salzano; I. Campia; S. Lusa; D. Ghigo; G. De Rosa; C. Riganti
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells
2010-01-01 I. Campia; C. Riganti; C. Voena; J. Kopecka; E. Enrico; C. Costamagna; D. Ghigo; A. Bosia
Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway.
2014-01-01 P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia.
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance.
2013-01-01 Chiara Riganti; Barbara Rolando; Joanna Kopecka; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier.
2013-01-01 ML. Pinzón-Daza; I. Campia; J. Kopecka; R. Garzón; D. Ghigo; C. Riganti
Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells
2011-01-01 Kopecka J; Campia I; Brusa D; Doublier S; Matera L; Ghigo D; Bosia A; Riganti C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells | 2011 | Kopecka J; Campia I; Olivero P; Pescarmona GP; Ghigo D; Bosia A; Riganti C | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells | 2015 | Campia, Ivana; Buondonno, Ilaria; Castella, Barbara; Rolando, Barbara; Kopecka, Joanna; Gazzano, Elena; Ghigo, Dario; Riganti, Chiara | |
| Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells | 2015 | J. Kopecka; I. Campia; A. Jacobs; AP. Frei; D. Ghigo; B. Wollscheid; C. Riganti | |
| Cardiac glycosides as new modulators of cholesterol metabolism | 2012 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
| Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation | 2013 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
| Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1 | 2012 | I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti | |
| Classical inhibitors of NOX NAD(P)H oxidases are not specific | 2008 | Aldieri E; Riganti C; Polimeni M; Gazzano E; Lussiana C; Campia I; Ghigo D | |
| Digoxin and ouabain increase the synthesis of cholesterol in human liver cells | 2009 | Campia I; Gazzano E; Pescarmona G; Ghigo D; Bosia A; Riganti C | |
| Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1alpha in human colon cancer cells | 2009 | Riganti C; Campia I; Polimeni M; Pescarmona G; Ghigo D; Bosia A | |
| Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes. | 2012 | Campia I; Sala V; Kopecka J; Leo C; Mitro N; Costamagna C; Caruso D; Pescarmona G; Crepaldi T; Ghigo D; Bosia A; Riganti C. | |
| Digoxin and oubain increase the synthesis of cholesterol in human liver cells | 2011 | Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti | |
| Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis | 2009 | Campia I; Lussiana C; Pescarmona GP; Ghigo D; Bosia A; Riganti C | |
| IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS | 2011 | Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition. | 2014 | J. Kopecka; G. Salzano; I. Campia; S. Lusa; D. Ghigo; G. De Rosa; C. Riganti | |
| Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells | 2010 | I. Campia; C. Riganti; C. Voena; J. Kopecka; E. Enrico; C. Costamagna; D. Ghigo; A. Bosia | |
| Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway. | 2014 | P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia. | |
| Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance. | 2013 | Chiara Riganti; Barbara Rolando; Joanna Kopecka; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo | |
| Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier. | 2013 | ML. Pinzón-Daza; I. Campia; J. Kopecka; R. Garzón; D. Ghigo; C. Riganti | |
| Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells | 2011 | Kopecka J; Campia I; Brusa D; Doublier S; Matera L; Ghigo D; Bosia A; Riganti C |